Back to Results

Effects of pubertal blockade and hormone therapy on cardiometabolic risk markers in transgender adolescents

Study category: Pediatrics

Is this Study for You?

Let's Get Started!

Description

There will be 6 study visits over about a year. They will take place over 2 days before starting testosterone and then 1 month and 12 months after starting testosterone. The first study visit will involve a blood draw, an oral glucose tolerance test (sugar drink) and answering questionnaires. The second day will involve an ultrasound of the arteries in the arm, abdominal MRI, exercise bike test and a body scan to evaluate fat and bone density. Participants will wear a sleep and activity monitor for a week after the second visit day.

Details
Age

Child

Eligibility

Age 13-16 years, going to start testosterone within the next 6 months

Detailed Eligibility: Cannot be on a medication containing estrogen or progesterone or on an antipsychotic medication.

Phase

Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.

Type of Study

Observational

Locations

Childrens Hospital Colorado
University of Colorado Hospital

Principal Investigator
Natalie Nokoff,  MD

Natalie Nokoff, MD

Study ID

Protocol Number: 17-2328

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers